Traversa Sergio

Avg. Two Year Performance

(76%) Avg. Purchase Return
(33%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(36%)(54%)(14%)(74%)(76%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

Relmada Therapeutics, Inc.

Drugs » Drugs - Generic

Chief Executive Officer, Director:

Holdings: 384.02K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Actinium Pharmaceuticals, I...

Other » Other

Director:

Holdings: 3.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--